SRC and ovarian cancer: The top canonical pathways predicted to be deactivated include ovarian cancer signaling (Z-score = −1), colorectal cancer metastasis signaling (Z-score = −1.941), and acute myeloid leukemia signaling (Z-score = −1.414), associated with Wnt family genes, RAS family genes, and SRC family kinases.